Margaret Eichleay

452 total citations
16 papers, 351 citations indexed

About

Margaret Eichleay is a scholar working on Nephrology, General Health Professions and Economics and Econometrics. According to data from OpenAlex, Margaret Eichleay has authored 16 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 6 papers in General Health Professions and 6 papers in Economics and Econometrics. Recurrent topics in Margaret Eichleay's work include Dialysis and Renal Disease Management (10 papers), Healthcare Policy and Management (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Margaret Eichleay is often cited by papers focused on Dialysis and Renal Disease Management (10 papers), Healthcare Policy and Management (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Margaret Eichleay collaborates with scholars based in United States, Canada and Japan. Margaret Eichleay's co-authors include Emily Evens, Philip J. Held, Avi Dor, Mark V. Pauly, Kayla Stankevitz, Caleb Parker, Friedrich K. Port, Ronald L. Pisoni, David C. Mendelssohn and Ron Wald and has published in prestigious journals such as SHILAP Revista de lepidopterología, Kidney International and Evaluation and Program Planning.

In The Last Decade

Margaret Eichleay

15 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margaret Eichleay United States 9 165 79 64 62 55 16 351
Hongying Tang United Kingdom 15 168 1.0× 94 1.2× 26 0.4× 10 0.2× 34 0.6× 49 697
Anirudh Rao United Kingdom 13 171 1.0× 53 0.7× 54 0.8× 8 0.1× 31 0.6× 38 528
R. Raj United States 11 121 0.7× 64 0.8× 105 1.6× 11 0.2× 59 1.1× 43 440
Sabrina Milan Manani Italy 11 268 1.6× 42 0.5× 39 0.6× 32 0.5× 46 0.8× 44 455
Syi Su Taiwan 12 32 0.2× 28 0.4× 79 1.2× 42 0.7× 46 0.8× 29 417
Steve Schwab United States 7 273 1.7× 16 0.2× 35 0.5× 42 0.7× 29 0.5× 20 390
Shang‐Chih Liao Taiwan 13 167 1.0× 61 0.8× 11 0.2× 36 0.6× 7 0.1× 28 390
Adanze Onyenonachi Asinobi Nigeria 11 191 1.2× 70 0.9× 8 0.1× 49 0.8× 9 0.2× 47 401
Wai-ming Lai Hong Kong 12 167 1.0× 17 0.2× 21 0.3× 10 0.2× 14 0.3× 21 297
Parsa Mirhaji United States 15 18 0.1× 43 0.5× 16 0.3× 21 0.3× 30 0.5× 43 600

Countries citing papers authored by Margaret Eichleay

Since Specialization
Citations

This map shows the geographic impact of Margaret Eichleay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Eichleay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Eichleay more than expected).

Fields of papers citing papers by Margaret Eichleay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret Eichleay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Eichleay. The network helps show where Margaret Eichleay may publish in the future.

Co-authorship network of co-authors of Margaret Eichleay

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret Eichleay. A scholar is included among the top collaborators of Margaret Eichleay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret Eichleay. Margaret Eichleay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chin‐Quee, Dawn, et al.. (2022). How Much Do Side Effects Contribute to Discontinuation? A Longitudinal Study of IUD and Implant Users in Senegal. SHILAP Revista de lepidopterología. 2. 804135–804135. 3 indexed citations
2.
Parker, Caleb, Emily Evens, Kayla Stankevitz, et al.. (2021). Adding unmanned aerial vehicles to HIV supply chains in remote settings: modeling feasibility and cost in Turkana, Kenya. SHILAP Revista de lepidopterología. 5. 3 indexed citations
3.
Eichleay, Margaret, Emily Evens, Kayla Stankevitz, & Caleb Parker. (2019). Using the Unmanned Aerial Vehicle Delivery Decision Tool to Consider Transporting Medical Supplies via Drone. Global Health Science and Practice. 7(4). 500–506. 70 indexed citations
4.
Burke, Holly M., Samuel Field, Lazáro Gonzaléz‐Calvo, Margaret Eichleay, & Troy D. Moon. (2019). Quasi-experimental evaluation using confirmatory procedures: A case study of an economic and social empowerment intervention to reduce girls’ vulnerability to HIV in rural Mozambique. Evaluation and Program Planning. 77. 101721–101721. 8 indexed citations
5.
Evens, Emily, et al.. (2013). POST-ABORTION CARE SERVICES FOR YOUTH AND ADULT CLIENTS IN KENYA: A COMPARISON OF SERVICES, CLIENT SATISFACTION AND PROVIDER ATTITUDES. Journal of Biosocial Science. 46(1). 1–15. 38 indexed citations
6.
McFarlane, Philip A., Ronald L. Pisoni, Margaret Eichleay, et al.. (2010). International trends in erythropoietin use and hemoglobin levels in hemodialysis patients. Kidney International. 78(2). 215–223. 63 indexed citations
7.
Wíkström, Björn, Stefan H. Jacobson, Jennifer L. Bragg‐Gresham, et al.. (2010). Dialysis Outcomes and Practice Patterns Study estimate of patient life-years attributable to modifiable haemodialysis practices in Sweden. Scandinavian Journal of Urology and Nephrology. 44(2). 113–120. 4 indexed citations
8.
Canaud, Bernard, Christian Combe, Jennifer L. Bragg‐Gresham, et al.. (2008). Gain de vie potentiel pour les patients hémodialysés français attribuable aux modifications des pratiques et la mise en conformité avec les cibles recommandées : une estimation permise par l’étude DOPPS. Néphrologie & Thérapeutique. 4(4). 256–265. 8 indexed citations
9.
10.
Saitō, Akira, Takashi Akiba, Tadao Akizawa, et al.. (2008). The DOPPS estimate of patient life years attributable to modifiable hemodialysis-Practices in Japan-. Nihon Toseki Igakkai Zasshi. 41(8). 473–482. 2 indexed citations
11.
Jadoul, Michel, Norbert Lameire, J.L. Bragg-Gresham, et al.. (2007). DOPPS ESTIMATE OF PATIENT LIFE YEARS ATTRIBUTABLE TO MODIFIABLE HAEMODIALYSIS PRACTICES IN BELGIUM. Acta Clinica Belgica. 62(2). 102–110. 3 indexed citations
12.
Dor, Avi, Mark V. Pauly, Margaret Eichleay, & Philip J. Held. (2007). End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF). International Journal of Health Care Finance and Economics. 7(2-3). 73–111. 79 indexed citations
13.
Wíkström, Björn, Michael Fored, Margaret Eichleay, & Stefan H. Jacobson. (2007). The financing and organization of medical care for patients with end-stage renal disease in Sweden. International Journal of Health Care Finance and Economics. 7(4). 269–281. 22 indexed citations
14.
Fukuhara, Shunichi, Chikao Yamazaki, Yasuaki Hayashino, et al.. (2007). The organization and financing of end-stage renal disease treatment in Japan. International Journal of Health Care Finance and Economics. 7(2-3). 217–231. 33 indexed citations
15.
Mendelssohn, David C., Karen Yeates, Jean Éthier, et al.. (2007). DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in Canada.. PubMed. 21(5). 69–70, 72, 74. 11 indexed citations
16.
Yeates, Karen, David C. Mendelssohn, Jean Éthier, et al.. (2007). Optimizing hemodialysis practices in Canada could improve patient survival.. PubMed. 17(2). 22–34. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongying Tang Breakdown of academic impact, for papers by Anirudh Rao Breakdown of academic impact, for papers by R. Raj Breakdown of academic impact, for papers by Sabrina Milan Manani Breakdown of academic impact, for papers by Syi Su Breakdown of academic impact, for papers by Steve Schwab Breakdown of academic impact, for papers by Shang‐Chih Liao Breakdown of academic impact, for papers by Adanze Onyenonachi Asinobi Breakdown of academic impact, for papers by Wai-ming Lai Breakdown of academic impact, for papers by Parsa Mirhaji
Rankless by CCL
2026